Cargando…

Central Nervous System Toxicity of Voriconazole: Risk Factors and Threshold – A Retrospective Cohort Study

PURPOSE: Voriconazole (VRC) is an antifungal agent which is used for treatment and prophylaxis of invasive fungal infections. The common clinical adverse reactions mainly include central nervous system (CNS) toxicity and abnormal liver function. These adverse reactions limit the clinical use of vori...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Luting, Wang, Chuhui, Zhang, Yijing, Wang, Quanfang, Qiu, Yulan, Li, Sihan, Yang, Bo, Du, Qian, Chen, Jiaojiao, Teng, Mengmeng, Wang, Taotao, Dong, Yalin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9766498/ https://www.ncbi.nlm.nih.gov/pubmed/36561883 http://dx.doi.org/10.2147/IDR.S391022

Ejemplares similares

Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy
por: Chen, Jiaojiao, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients
por: Han, Ruiying, et al.
Publicado: (2021)

Choosing Optimal Antibiotics for the Treatment of Patients Infected With Enterobacteriaceae: A Network Meta-analysis and Cost-Effectiveness Analysis
por: Han, Ruiying, et al.
Publicado: (2021)

Modeling and Simulation as a Tool to Assess Voriconazole Exposure in the Central Nervous System
por: Staudt, Keli Jaqueline, et al.
Publicado: (2023)

Application of a Physiologically Based Pharmacokinetic Model to Characterize Time-dependent Metabolism of Voriconazole in Children and Support Dose Optimization
por: Zhang, Yahui, et al.
Publicado: (2021)

A strategy for designing voriconazole dosage regimens to prevent invasive pulmonary aspergillosis based on a cellular pharmacokinetics/pharmacodynamics model
por: Wang, Taotao, et al.
Publicado: (2018)

Clinical Analysis of Intravenous and Oral Sequential Treatment With Voriconazole for Candida Central Nervous System Infection in Six Premature Infants
por: Zhu, Yingying, et al.
Publicado: (2021)

Metallo-β-lactamases immobilized by magnetic zeolitic imidazolate frameworks-8 for degradation of β-lactam antibiotics in an aqueous environment
por: Wang, Quanfang, et al.
Publicado: (2023)

Central nervous system toxicity of metallic nanoparticles
por: Feng, Xiaoli, et al.
Publicado: (2015)

Rechallenge of voriconazole successfully tolerated after hepatic toxicity
por: Narumoto, O., et al.
Publicado: (2020)

Metal toxicity in the central nervous system.
por: Clarkson, T W
Publicado: (1987)

Central nervous system toxicity of interferon.
por: Rohatiner, A. Z., et al.
Publicado: (1983)

Application of dental nanomaterials: potential toxicity to the central nervous system
por: Feng, Xiaoli, et al.
Publicado: (2015)

Role of Voriconazole in the Management of Invasive Central Nervous System Aspergillosis: A Case Series from a Tertiary Care Centre in India
por: Gupta, Nitin, et al.
Publicado: (2020)

Invasive trichosporonosis treated with voriconazole
por: Garg, Vaibhav, et al.
Publicado: (2018)

Factors Affecting Voriconazole Trough Concentration and Optimal Maintenance Voriconazole Dose in Chinese Children
por: Zhao, Yi-Chang, et al.
Publicado: (2021)

Construction of a Nomogram for Predicting Survival in Elderly Patients With Lung Adenocarcinoma: A Retrospective Cohort Study
por: You, Haisheng, et al.
Publicado: (2021)

Population pharmacokinetics of voriconazole and initial dosage optimization in patients with talaromycosis
por: Jiang, Zhiwen, et al.
Publicado: (2022)

Toxic Effects of Mercury on the Cardiovascular and Central Nervous Systems
por: Fernandes Azevedo, Bruna, et al.
Publicado: (2012)

Potential toxicity of dental nanomaterials to the central nervous system
por: Solla, Davi Fontoura, et al.
Publicado: (2015)

Effects of Voriconazole on the Pharmacokinetics of Vonoprazan in Rats
por: Shen, Jiquan, et al.
Publicado: (2020)

The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro
por: Xu, Ren-ai, et al.
Publicado: (2018)

Response of chromoblastomycosis to voriconazole
por: de Lima, Alexandre Moretti, et al.
Publicado: (2016)

Serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy
por: Saini, Lalit, et al.
Publicado: (2014)

Responses to increasing exercise upon reaching the anaerobic threshold, and their control by the central nervous system
por: Peinado, Ana B, et al.
Publicado: (2014)

Identifying the Threshold of Iron Deficiency in the Central Nervous System of the Rat by the Auditory Brainstem Response
por: Greminger, Allison R., et al.
Publicado: (2015)

Sustained-release voriconazole-thermogel for subconjunctival injection in horses: ocular toxicity and in-vivo studies
por: Mora-Pereira, Mariano, et al.
Publicado: (2020)

Central Nervous System Toxicity After Botulinum Neurotoxin Injection
por: Ilkhchoui, Yashar, et al.
Publicado: (2013)

Therapeutic Effect of Intrastromal Voriconazole, Topical Voriconazole, and Topical Natamycin on Fusarium Keratitis in Rabbit
por: Nejabat, Mahmood, et al.
Publicado: (2016)

Voriconazole-refractory invasive aspergillosis
por: Park, Se Yoon, et al.
Publicado: (2017)

Voriconazole: Hepatotoxicity: case report
Publicado: (2021)

Voriconazole-Induced Diffuse Periostitis
por: Stefan, Simona, et al.
Publicado: (2022)

Effects of Electroacupuncture on Pain Threshold of Laboring Rats and the Expression of Norepinephrine Transporter and α2 Adrenergic Receptor in the Central Nervous System
por: Tang, Qianli, et al.
Publicado: (2016)

Tacrolimus interacts with voriconazole to reduce the severity of fungal keratitis by suppressing IFN-related inflammatory responses and concomitant FK506 and voriconazole treatment suppresses fungal keratitis
por: Zhong, Jing, et al.
Publicado: (2018)

Inflammation Affects Liver Function and the Metabolism of Voriconazole to Voriconazole-N-Oxide in Adult and Elderly Patients
por: Liang, Zaiming, et al.
Publicado: (2022)

Microdialysis of Drug and Drug Metabolite: a Comprehensive In Vitro Analysis for Voriconazole and Voriconazole N-oxide
por: Schulz, Josefine, et al.
Publicado: (2022)

Factors influencing plasma concentration of voriconazole and voriconazole- N-oxide in younger adult and elderly patients
por: Cheng, Lin, et al.
Publicado: (2023)

A neonatal mouse model of central nervous system infections caused by Coxsackievirus B5
por: Mao, Qunying, et al.
Publicado: (2018)

The Initial Myelination in the Central Nervous System
por: Yu, Qiang, et al.
Publicado: (2023)

Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure
por: Dong, Yuzhu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i7p84u9rmhnprc0j6or32gh35i